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The hypothalamo-pituitary-adrenal (HPA) axis plays a key role in the neuroendocrine response 
to stress and in maintaining physiological homeostasis. However, stress that is chronic in 
nature can lead to HPA axis dysfunction and increase the risk for developing affective 
disorders, particularly if the stress is experienced during vulnerable periods in life. Sex 
differences in how the HPA axis responds to stress are well established, with females typically 
displaying heightened responses. The underlying cause of these sex differences are important 
to understand, as many neuropsychiatric disorders disproportionately affect females.  
Much research has provided evidence for gonadal sex steroids in underpinning sex differences 
in HPA axis responsivity, however we suggest that neuroactive metabolites of these steroids 
also play a key role in the brain in mediating sex differences in HPA axis responses to stress. 
The relationship between neuroactive steroids and stress is complex. Acute stress rapidly 
increases neuroactive steroid production, which can in turn modulate activity of the HPA axis. 
However under chronic stress conditions, stress can impact the brain’s capacity to generate 
steroids, and this in turn has corollary effects on HPA axis function that may increase the 
propensity for psychopathology, given both HPA axis dysfunction and deficits in neuroactive 
steroids are implicated in affective disorders. Hence here we review the evidence from animal 
and human studies for sex differences in the interactions between neuroactive steroids and 
the stress axis at various stages of life, under physiological and pathophysiological stress 





Although the term “stress” seemingly carries negative connotations, it represents an important 
physiological adaptation that is essential for an organism’s survival. The concept of “stress” 
was proposed by Walter Cannon (Cannon, 1914) and Hans Selye (Selye, 1936) as a process 
that brings about physiological adaptations that allow an organism to cope with changes in 
the environment or its internal milieu. More recently, stress has been viewed as part of a 
framework known as “allostasis”, defined as the process of “attaining stability through change” 
(McEwen, 2000). The typical response to stress involves activation of the sympathetic nervous 
system and the hypothalamo-pituitary-adrenal (HPA) axis, producing primary “allostatic 
mediators” such as catecholamines and glucocorticoids, which act on a range of systems to 
alter the organism’s physiology and behaviour (Chrousos & Gold, 1992). As stress responses 
are dynamic, they additionally involve several other “allostatic mediators” including 
neurotransmitters, neuropeptides and steroids in the brain (i.e. neuroactive steroids), which 
interact with each other in a non-linear manner. An alteration in one mediator may therefore 
lead to knock-on effects in other mediators, and the end product is a stress response with 
variable characteristics, depending on the nature, severity, and duration of the stressor. 
Notably, stress that is chronic, severe or experienced during vulnerable periods in life is viewed 
as a physiological burden or “allostatic load”, which may lead to the dysregulation of certain 
mediators, and in turn, an increased risk of an organism developing stress-related pathologies. 
The sex of an individual adds an additional layer of complexity to the dynamic nature of stress 
responses, as males and females exhibit marked differences in the extent of their stress 
responses, and critically in the incidence of stress-related disorders.  
Sex differences in stress responses are attributed to the effects of sex-specific genes, as well 
as the effects of gonadal hormones (e.g. testosterone, estradiol, and progesterone) acting in 
the periphery or in the brain to exert their effects. The “organisational-activational hypothesis” 
of hormone-driven sexual differentiation (Phoenix et al., 1959) posits that masculinisation of 
neural circuits associated with sexual behaviour results from differential exposure to testicular 
hormones both early in development and during adulthood. However, how exactly these 
gonadal steroids exert their action in the brain to mediate processes, especially those not 
directly associated with reproductive behaviour (e.g. stress responses), have not been fully 
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elucidated. This is further complicated by the complexity in the regulation of steroid action in 
the brain, as the brain is also a steroidogenic organ and has the capacity to produce or further 
metabolise steroids, especially in response to stress. These steroids that are produced 
endogenously in the brain are termed “neurosteroids”, and have properties that are specific 
for their action in the brain, such as the ability to rapidly modulate neuronal transmission 
(Baulieu, 1991; Rupprecht, 2003). However, due to the difficulties in establishing the source 
and actions of steroids found in the brain, the umbrella term “neuroactive steroids” is more 
commonly used to refer to all steroids found in the brain that are able to regulate neural 
functions (Melcangi et al., 2008). Neuroactive steroids (which by definition, includes gonadal 
steroids and adrenocorticosteroids that enter the brain) therefore lie at the intersection of sex 
differences and the modulation of stress responses.  
This review will first describe sex differences in stress responses, with a particular focus on the 
HPA axis, due to the observation that HPA axis dysregulation underlies many stress-related 
psychopathologies (McEwen, 2003; Pariante & Lightman, 2008; Fernandez-Guasti et al., 2012; 
Altemus et al., 2014; Rincón-Cortés et al., 2019). The role of gonadal steroids in establishing 
sex differences in HPA axis responsivity will be discussed, with an emphasis on the metabolism 
of these gonadal steroids to their downstream neuroactive metabolites in the brain. Sex 
differences in how the brain responds to stress may account for the sex bias in the propensity 
to develop stress-related disorders, hence sex differences in the levels of neuroactive steroids 
will be compared during the physiological response to acute stress, as well as under chronic 
stress conditions and in psychiatric disorders. The bi-directional relationship between steroids 
and stress will be explored by considering not only the role of neuroactive steroids in 
establishing and maintaining differences in stress responsivity across the lifespan, but also the 
impact of pathophysiological stress during critical periods of development on the brain’s 
capacity to generate neurosteroids, and the knock-on effects for HPA axis regulation and 
mood. 
REGULATION OF THE HPA AXIS 
The core components of the HPA axis include the medial parvocellular region of the 
paraventricular nucleus (mpPVN) of the hypothalamus, the anterior pituitary gland and the 
cortical region of the adrenal glands. Following stressful stimuli, neurones of the mpPVN are 
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activated and release the peptides corticotropin-releasing hormone (CRH) and arginine 
vasopressin (AVP) at the median eminence into the hypophysial portal blood system that 
supplies the anterior pituitary gland. CRH and AVP stimulate the synthesis and secretion of 
adrenocorticotropic hormone (ACTH) by the anterior pituitary corticotrophs into the general 
circulation. ACTH in turn stimulates the adrenal cortex to secrete glucocorticoids into the 
bloodstream (cortisol in humans and corticosterone in rats and mice). ACTH and 
corticosterone secretion display a circadian rhythm with lowest levels at the onset of the 
inactive phase (i.e. the morning in rats, the evening in humans)  and highest levels at the onset 
of the  active phase (i.e. the evening in rats, the morning in humans) (Meaney et al., 1992; 
Atkinson et al., 2006). Glucocorticoids function to redistribute energy across the body, promote 
processes related to energy mobilisation in the brain and skeletal muscles, but inhibit 
processes related to growth, development, reproduction and immunity (Munck et al., 1984; 
Sapolsky et al., 2000). Glucocorticoids act by binding to glucocorticoid (GR) and 
mineralocorticoid receptors (MR), both of which are expressed in the brain, but show 
differential regional expression patterns and binding affinities (de Kloet et al., 1998). 
Glucocorticoids primarily signal via MR under basal conditions, and act through GR mainly in 
instances where higher concentrations are present, such as during stress, or during the peak 
of the circadian rhythm (de Kloet et al., 1998). Given the widespread actions of glucocorticoids, 
the magnitude of their production (i.e. activation of the HPA axis), as well as the termination 
of their production (i.e. inhibition of the HPA axis) is tightly controlled.  
Activation of the HPA axis relies largely on complex neural circuits and is stressor-dependent 
(Godoy et al., 2018). Physical stressors such as inflammation, haemorrhage, or pain signal 
through direct noradrenergic and adrenergic projections originating from the nucleus of the 
solitary tract (NTS) and ventrolateral medulla (VLM) of the brainstem to the PVN (Ulrich-Lai & 
Herman, 2009); whereas psychological stressors which require appraisal of an event as 
‘stressful’ activate more complex pathways, relying heavily on signal processing by limbic 
structures such as the hippocampus, prefrontal cortex, and amygdala (Godoy et al., 2018; de 
Kloet et al., 2019). Communication between these brain regions rely on neural circuitries 
involving GABA and glutamate neurotransmission (Ulrich-Lai & Herman, 2009). Signals from 
different limbic regions are integrated at regions such as the peri-PVN, the bed nucleus of the 
stria terminalis (BNST), and the medial preoptic area (mPOA), which directly innervate the PVN, 
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eventually resulting in the production of CRH and/or AVP in the mpPVN neurones (Ulrich-Lai 
& Herman, 2009; Bains et al., 2015). Stress also leads to the production and secretion of other 
allostatic steroid mediators from the adrenal glands, such as deoxycorticosterone (DOC) and 
progesterone (Torres et al., 2001; Reddy, 2006; Hueston & Deak, 2014).  
Activation of the HPA axis is followed by inhibitory mechanisms to shut the axis down once 
the stress no longer poses a threat (Herman, 2013). Inhibition of the HPA axis is controlled by 
both rapid neuronal signalling mechanisms, as well as other slower genomic mechanisms that 
involve gene expression changes (Ulrich-Lai & Herman, 2009). One of the key inhibitory 
mechanisms regulating HPA axis activity is the negative feedback inhibition mediated by 
glucocorticoid binding to GR, directly in CRH-producing neurones of the PVN, as well as in 
anterior pituitary corticotrophs (Keller-Wood & Dallman, 1984; Uht et al., 1988) and indirect 
inhibition via glucocorticoid actions on GR and MR expressed in other limbic structures, such 
as the hippocampus (Herman et al., 2005). GABA neurotransmission is an important aspect of 
HPA axis inhibition, as the PVN is directly innervated by GABA projections from various brain 
regions, including the peri-PVN and the BNST (Cullinan et al., 1993; Herman et al., 2016). 
Notably, neuroactive steroids such as the progesterone metabolite allopregnanolone and 
corticosterone metabolite, tetrahydrodeoxycorticosterone (THDOC), concentrations of which 
both increase considerably following acute stress, positively modulate GABAA receptors via an 
allosteric binding site to potentiate inhibitory GABAergic signalling (Purdy et al., 1991; 
Barbaccia et al., 1996; Hosie et al., 2006; Girdler & Klatzkin, 2007). Given these actions, 
increased allopregnanolone and THDOC following stress have been proposed to constitute a 
negative feedback mechanism which aids termination of the HPA axis response (Wirth, 2011; 
Crowley & Girdler, 2014; Gunn et al., 2015; Brunton, 2016). Indeed, in vivo experiments in rats 
confirm that pretreatment with either allopregnanolone or THDOC significantly attenuates 
stress-induced increases in plasma ACTH and corticosterone concentrations, possibly through 
the inhibition of CRH-producing neurones in the mpPVN (Owens et al., 1992; Patchev et al., 
1996; Brunton et al., 2009), further supporting their inhibitory role in the regulation of the HPA 
axis.  
Sex differences in HPA axis function under physiological stress conditions 
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Sex differences in HPA axis stress responses in rodents are well established, and have been 
extensively reviewed elsewhere (Goel et al., 2014; Handa & Weiser, 2014; Oyola & Handa, 2017; 
Heck & Handa, 2019). Although some inconsistencies are reported, possibly due to different 
experimental conditions, in general, stress induces a more robust activation of the HPA axis in 
females than in males. 
Sex differences in responses to acute stress in rodents 
Under stress-free conditions, females generally show greater baseline plasma corticosterone 
concentrations (Kitay, 1961; Handa et al., 1994) and more pulses in the circadian rhythm of 
corticosterone secretion, compared with males (Atkinson & Waddell, 1997; Goel et al., 2014). 
However this difference is not reflected in the brain (Droste et al., 2009); possibly due to the 
higher levels of corticosteroid-binding globulin (CBG) present in the female circulation (Gala 
& Westphal, 1965). While basal circulating ACTH concentrations generally do not show sex 
differences (Viau et al., 2005; Goel et al., 2014), greater Crh expression in the mpPVN is typically 
reported in females (Viau et al., 2005; Iwasaki-Sekino et al., 2009; Goel et al., 2014). Following 
an acute stressor, activation of the HPA axis is typically greater in female rodents than in males, 
reflected by the secretion of greater absolute amounts of corticosterone into the circulation, 
at a faster rate than in males, greater neuronal activation (c-Fos expression) of the PVN 
neurones (Babb et al., 2013), and greater increases in Crh expression (Iwasaki-Sekino et al., 
2009)(Fig. 1). In the periphery, the pituitary gland is more sensitive to stimulation by CRH and 
the adrenal glands are more sensitive to ACTH in females (Fig. 1), with the latter evidently 
mediated by estradiol actions (Figueiredo et al., 2007; Goel et al., 2014). In terms of the 
inhibition of the HPA axis, it seems that there is diminished GR-mediated negative-feedback 
control of the HPA axis in females, resulting in a slower resolution of the stress response 
(Burgess & Handa, 1992).  
Sex differences in responses to acute stress in humans 
Sex differences in cortisol responses to psychological stress are also reported in humans (Goel 
et al., 2014), however the direction of difference is less consistent than those observed in 
rodents (Kirschbaum et al., 1992; Seeman et al., 2001; Kudielka & Kirschbaum, 2005; Uhart et 
al., 2006; Rao & Androulakis, 2017). These inconsistencies are compounded by the fact that 
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stress perception and general HPA axis function show far more inter-individual variability in 
humans (Goel et al., 2014; Rao & Androulakis, 2017; van der Voorn et al., 2017), and patterns 
of cortisol production do not always appear to correlate with subjective stress responses 
(Gillies & McArthur, 2010).  
In the CRH-dexamethasone suppression test, the cortisol response is higher in women than in 
men (Heuser et al., 1994; Kunugi et al., 2006), indicating lower sensitivity to glucocorticoid-
mediated negative feedback inhibition. However, in stressed-based tasks, such as the Trier 
Social Stress Test (TSST), which involves public speaking and a mental arithmetic task, some 
studies report no differences in plasma cortisol and ACTH responses between the sexes, while 
others report concentrations to be generally higher in males (Kudielka & Kirschbaum, 2005). 
On the other hand, women tend to show greater responsivity to social rejection, thus the HPA 
axis responses to stress in humans are likely to be very much stressor-dependent (Stroud et 
al., 2002).   
Mechanisms underlying sex differences in the response to physiological stress 
Sex differences in physiological responses to stress can be attributed to the actions of gonadal 
steroids and the genetic sex of the organism (Becker et al., 2005). The central concept of the 
organisational-activational effects of gonadal steroids, first proposed by Phoenix et al. 
(Phoenix et al., 1959) states that sex differences in the brain and behaviour are permanently 
sexually differentiated by testosterone during early critical periods of development (i.e. 
“organisational effects”), and these ‘organised’ characteristics are brought to expression during 
adulthood due to the continued presence of these gonadal hormones (i.e. “activation” effects) 
(McCarthy et al., 2012, Arnold, 2009) (Fig. 2). Although the initial study specifically examined 
sexual behaviour, this framework can also be applied to other phenotypes that show sexual 
differentiation (Blaustein & McCarthy, 2009). 
In male rats, a testosterone surge occurs around gestational day 18 and again during the hours 
shortly after birth, where levels are significantly higher than those measured in female siblings 
(Weisz & Ward, 1980). Male neonatally gonadectomised rats have greater circulating 
corticosterone concentrations and Fos activation in the mpPVN, both under basal conditions 
and after 30 min of restraint exposure (Bingham & Viau, 2008). These effects can be normalised 
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with testosterone treatment on postnatal day (PND) 1-5, but not during adulthood, indicating 
organisational effects of testosterone during the early postnatal period (Bingham & Viau, 
2008). More recent studies have also proposed that “organisational” effects also occur during 
puberty, when there are further maturational changes in the neural circuitry of the brain, due 
to the epigenetic effects of gonadal hormones (Schulz et al., 2009; Morrison et al., 2014).  
During adulthood, steroids present in the brain, exert direct “activational” effects on cellular 
function, which are only observed when the steroids are present. Generally, testosterone 
dampens, while estrogen potentiates HPA axis function (Goel et al., 2014; Handa & Weiser, 
2014; Heck & Handa, 2019). Hence removal of the testes (and thus the main source of 
androgens) increases basal corticosterone levels, as well as stress-induced corticosterone 
secretion in males to “female-like” levels; whereas testosterone administration after 
gonadectomy reduces ACTH and corticosterone production (Seale et al., 2004). In contrast, 
removal of the ovaries results in lower baseline corticosterone levels and attenuated 
corticosterone secretory responses to stress, compared with intact females; an effect that can 
be normalised with estrogen replacement (Seale et al., 2004; Babb et al., 2013). Hormonal 
changes during the estrous cycle also contribute to the activational effects of steroids, with 
basal concentrations of ACTH and corticosterone highest at proestrus, when estradiol levels 
peak (Atkinson & Waddell, 1997). Progesterone also plays a modulatory role in regulating the 
HPA axis in females, but in contrast to estradiol, progesterone has a seemingly inhibitory 
action, as it prevents the enhancing effects of estrogen on stress-induced ACTH secretion in 
rats (Viau & Meaney, 1991; Roy et al., 1999). These gonadal steroids can thus be considered 
mediators of allostasis, where changes in their secretion in response to stress, can in turn shape 
HPA axis stress responses. 
Although the organisational-activational theory for sexual differentiation has been widely 
applied, there are several unanswered and unaddressed questions surrounding this theory 
(Arnold, 2009; Lenz et al., 2012; McCarthy et al., 2017). Of particular relevance here is that 
although a wealth of studies support a critical role for gonadal steroids in mediating sex 
differences in stress responses, the underlying molecular mechanisms of steroid action remain 
unclear. Hence, next we explore the evidence for neuroactive steroids in mediating the effects 
of gonadal steroids on the HPA axis and the resultant sex differences in responses to stress. 
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NEUROACTIVE STEROIDS  
Neuroactive steroids are active metabolites of classical steroid hormones that have rapid 
membrane actions on neuronal excitability. The brain expresses the enzymes necessary for 
neurosteroidogenesis (Compagnone and Mellon, 2000; Furukawa et al., 1998) in neurones and 
glia and can produce neurosteroids de novo from cholesterol (Baulieu, 1991;(Compagnone & 
Mellon, 2000). Indeed, neurosteroids continue to be detected in the brain after combined 
adrenalectomy and gonadectomy (Corpechot et al., 1993). The first step in 
neurosteroidogenesis involves the conversion of cholesterol to pregnenolone which is 
catalysed by steroidogenic acute regulatory protein (StAR) and p450 side-chain cleavage 
enzyme (p450scc) (Fig. 3). Pregnenolone is subsequently converted into a range of 
downstream progestogens, androgens, estrogens and corticosteroids (Fig. 3). In addition, the 
brain can metabolise circulating steroid precursors produced in the periphery into neuroactive 
steroids (Compagnone & Mellon, 2000). 
Gonadal sex steroids can be converted into neuroactive metabolites in the brain 
Gonadal sex steroids can be metabolised by steroidogenic enzymes such as 5α-reductase, 3α- 
and 3β-hydroxysteroid dehydrogenase (3α-HSD and 3β-HSD) in the brain (Compagnone & 
Mellon, 2000). For example, progesterone can be metabolised by 5α-reductase into 
dihydroprogesterone (DHP), which in turn is converted into allopregnanolone by 3α-HSD (Fig. 
3). Similarly, testosterone can be converted to dihydrotestosterone (DHT) by 5α-reductase and 
then into either 3α- or 3β-androstanediol (3α-diol and 3β-diol) through the actions of 3α-HSD 
and 3β-HSD, respectively (Fig. 3). The organisational actions of testosterone during the fetal 
surge are attributed to its conversion in the brain to estradiol (by aromatase), while its 
activational actions in adulthood are evidently a result of testosterone’s downstream 
conversion to DHT and androstanediol (Arnold, 2009). 
Neuroactive steroid signalling in the brain 
Classical genomic actions of steroids are mediated by binding to steroid receptors such as GR, 
MR, progesterone receptors (PR), androgen receptors (AR), and estrogen receptors (ER), which 
are all ligand-dependent transcription factors that bind to steroid responsive elements to 
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enhance or repress gene transcription (Beato, 1989)(Fig. 4). However, it has become clear over 
the past 20 years or so that steroids do not only act via classic steroid receptor actions, as 
many steroid-mediated cellular responses occur within minutes, which is generally considered 
too short a time frame for genomic effects to occur (Makara & Haller, 2001; Simoncini & 
Genazzani, 2003).  
Indeed, steroids can also exert rapid, neurotransmitter-like actions — they can bind to steroid 
receptors that do not exert direct genomic effects (e.g. those that are membrane bound, or 
those that are located in the cytosol but signal through other receptors), or bind to receptors 
that are not classical steroid receptors (e.g. transmembrane ion-channel receptors) (Cato et al., 
2002). These downstream effects that are rapid and do not directly affect gene expression, are 
defined as non-genomic actions of steroids (Lösel & Wehling, 2003). There are a wide range 
of receptors that steroids can act upon to exert non-genomic actions (for review see 
(Rupprecht, 2003); Fig. 4), but perhaps the most well characterised are the rapid allosteric 
actions on the GABAA receptors, resulting in a potentiation of GABA action (Groeneweg et al., 
2011; Gunn et al., 2011). 3α,5α-reduced metabolites of DOC, progesterone, and testosterone 
(i.e. THDOC, allopregnanolone and 3α-diol, respectively) bind to a site distinct from the GABA 
binding region, opening the ion channel and permitting the enhanced influx of Cl- ions by 
increasing both the channel opening frequency and the channel opening duration, which leads 
to sustained hyperpolarisation of the neurone and increased inhibition of neural activity 
(Majewska et al., 1986; Morrow et al., 1987; Lambert et al., 2001; Hosie et al., 2006; Akk et al., 
2007). Through these GABAA-mediated actions, allopregnanolone and THDOC are able to 
temper HPA axis activity (Gunn et al., 2015).   
Neuroactive steroids modulate stress responses 
Neuroactive metabolites of sex steroids play important roles in modulating HPA axis function. 
As mentioned above, allopregnanolone and THDOC facilitate termination of the stress 
response (Purdy et al., 1991). Moreover, allopregnanolone and THDOC attenuate stress-
induced HPA axis activity in male and female rats (Owens et al., 1992; Patchev et al., 1996; 
Brunton et al., 2009) and have anxiolytic actions (Patchev et al., 1994; Dubrovsky, 2005; Schule 
et al., 2011). Importantly, the effects of testosterone in dampening stress-evoked HPA axis 
activity can be blocked by central administration of the 5α-reductase inhibitor, finasteride, 
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indicating that 5α-reductase activity in the brain is crucial for testosterone’s actions (Handa et 
al., 2009). Indeed, the inhibitory effect of testosterone on HPA axis activity is actually mediated 
by its metabolite 3β-diol acting via central estrogen receptor beta (ERβ) (Lund et al., 2006; 
Foradori et al., 2008; Handa et al., 2009), whereas the anti-anxiety effects of 3α-diol act via a 
GABAA-mediated pathway (Frye et al., 1996; Edinger & Frye, 2005).  
Sex differences in neuroactive steroid levels and action in the brain  
In the adult rat brain, there are sex- and region-dependent differences in basal concentrations 
of neuroactive steroids (Caruso et al., 2010b; Caruso et al., 2013; Giatti et al., 2019b). In general, 
levels of ovarian hormones such as progesterone and its metabolites are greater in the brains 
of females, whilst testicular hormones such as testosterone and its metabolites, are higher in 
males (Table 1). Patterns of the steroidogenic enzymes are also expressed in a sex-specific 
manner in the rat brain. For example, in the cerebellum, gene expression for StAR (Stard1) and 
3α-HSD (Akr1c4) are significantly higher in females, whereas 5α-reductase expression is higher 
in males (Giatti et al., 2019a). As these sex differences have recently been reviewed (Giatti et 
al., 2019b), here we will focus on sex differences in neuroactive steroid levels in response to 
stress.  
Sex differences in neuroactive steroid levels under physiological stress conditions  
Rodent studies 
Acute stress increases the central expression of 5α-reductase in a region dependent manner 
in male rats (Sanchez et al., 2008a), however no studies have directly compared the impact of 
stress on steroidogenic enzyme expression in the brains of males and females. However, acute 
stress increases the levels of several neuroactive steroids in the brain (Purdy et al., 1991; Vallée 
et al., 2000), and the increase is more pronounced in females than in males (Sze et al., 2018). 
Following acute swim stress, circulating corticosterone, DOC and progesterone concentrations 
are increased in both sexes; however, the levels are significantly greater in females compared 
to males (Sze et al., 2018). In the brain, this sex difference is also observed in the majority of 
brain regions for DOC and progesterone, but not for corticosterone (Sze et al., 2018). Notably, 
while stress-induced increases in allopregnanolone are observed in both sexes in the 
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prefrontal cortex, the effects are more marked in females, and in other regions such as the 
amygdala and brainstem, stress increases allopregnanolone concentrations only in female rats 
(Sze et al., 2018). Many of the steroids are evidently produced de novo in the brain in response 
to stress, as central concentrations of pregnenolone, DHP and dihydrodeoxycorticosterone 
(DHDOC) increase, despite no corresponding change in the circulation (Sze et al., 2018). Sex 
differences in neuroactive steroid levels in the brain after stress may be attributed to the 
differential availabilities of precursor steroids (e.g. progesterone), differential expression of 
steroidogenic enzymes (Giatti et al., 2019a), or may constitute a downstream effect of sex 
differences in central CRH production and/or action (Torres et al., 2001).  
Furthermore, it is unclear whether these sex differences in central neuroactive steroid levels 
following stress play a role in differential HPA axis responses to stress. Increased stress-
induced levels of allopregnanolone in the brain in females may be expected to result in a more 
rapid termination of the stress response, however this does not appear to be the case, as HPA 
axis stress responses resolve more slowly in females than in males (Burgess & Handa, 1992). 
This may be a result of progesterone acting as an antagonist at GRs (Svec, 1988), impeding 
glucocorticoid negative feedback. Nevertheless, greater allopregnanolone production in 
females following stress (Sze et al., 2018) may represent a compensatory inhibitory signalling 
mechanism to aid termination of the stress response. 
On the other hand, given limbic brain structures modulate the activity of the HPA axis via 
neural projections to GABAergic relay sites (e.g. in the peri-PVN and BNST)(Cullinan et al., 
2008), it is possible that sex differences in GABAA receptor-active neuroactive steroids (e.g. 
allopregnanolone) may lead to sex-dependent modulation of GABAergic signalling pathways 
upstream of the mpPVN. If this were the case it could be that in females there is greater 
disinhibition of CRH neurones in the mpPVN; an effect which would be expected to contribute 
to sex differences in HPA axis responses to stress.  
CHRONIC STRESS AND HPA AXIS DYSREGULATION  
Until now we have focussed on the physiological HPA axis response of a healthy adult 
organism to a single, acute stressor. However, depending on the severity, frequency, duration 
of the stressor, and the period of life in which the stressor is experienced, the HPA axis 
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response may differ considerably. While repeated homotypic stress may lead to the 
habituation of stress responses, chronic stress may result in sensitisation of stress responses, 
resulting in glucocorticoid production that is of greater amplitude or frequency (Melia et al., 
1994; Gomez et al., 1996; Ma & Lightman, 1998), leading to “allostatic load” (Diamond et al., 
1992; de Kloet et al., 1998). Prolonged allostatic load may eventually lead to “allostatic 
overload”, where the impacts of HPA axis dysregulation manifests as the failure of 
physiological systems and the onset of disease (Natelson et al., 1988; Belda et al., 2015; Kinlein 
et al., 2015). A hyperactive HPA axis is associated with mood disorders such as anxiety and 
depression, while insufficient activation of the HPA axis is often reported in patients with post-
traumatic stress disorder (PTSD) (Sherin & Nemeroff, 2011; Pitman et al., 2012). 
Increased glucocorticoid production may result from an increased drive towards the 
production of CRH and ACTH, or altered receptor sensitivity in the key regions regulating the 
HPA axis (e.g. CRH receptors in the anterior pituitary, ACTH receptors in the adrenal glands). 
HPA axis dysregulation can also manifest as prolonged secretion of glucocorticoids, which may 
stem from decreased feedback inhibition either by GR-mediated mechanisms, or other 
neurotransmitter systems (Levy & Tasker, 2012). For instance, chronic stress-induced hyper-
reactivity of the HPA axis is associated with an imbalance between excitatory and inhibitory 
signals, where there is generally increased excitatory (Flak et al., 2009) and decreased inhibitory 
neurotransmission (Verkuyl et al., 2004). Prolonged stress may also induce neuroactive steroid 
tolerance at the GABAA receptor, leading to the inability to properly terminate the HPA axis 
response (Turkmen et al., 2011). In support, the levels of the GABAA-modulatory neuroactive 
steroids, such as allopregnanolone and THDOC, are decreased in the brain following chronic 
stress in male mice and rats (Serra et al., 2000; Dong et al., 2001), while Srd5a expression has 
also been reported to be decreased following chronic stress in male mice (Agis-Balboa et al., 
2007). In clinical studies, levels of endogenous 3α-reduced neuroactive steroids in plasma and 
cerebrospinal fluid (CSF) are decreased in patients with affective disorders, whereas elevated 
neuroactive steroid levels are associated with anti-depressant actions (Uzunova et al., 2006; 
Schule et al., 2014). 
Sex differences in HPA axis function under pathophysiological stress conditions  
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As a result of the underlying differences in physiology between males and females, 
consequences of “allostatic load” may differ between the sexes. Therefore, changes in the brain 
and behaviour following chronic or severe stress may be different for males and females, even 
if the same stressor is applied (Goel et al., 2014).  
Rodent studies of chronic stress 
Chronic stress alters HPA axis function, however, animal models of chronic stress have mainly 
used male rodents, and there is a relative paucity of information for females, or direct 
comparative studies between males and females (Heck & Handa, 2019). A few studies have 
reported that females display more pronounced HPA axis dysregulation following chronic 
stress, with greater increases in corticosterone secretion (Dalla et al., 2005; Vieira et al., 2018). 
However, more studies are necessary to fully understand sex differences in responses to 
chronic stress. For example, it is not known whether the reduction in THDOC and 
allopregnanolone following chronic stress reported in male rodents (Serra et al., 2000; Dong 
et al., 2001) also occurs in females, and if so whether this effect is more or less pronounced 
than in males. This is important to establish as loss of this regulatory neuroactive steroid action 
is proposed to underlie stress-related disorders (Schule et al., 2014; Maguire, 2019), for which 
males and females display different susceptibilities (Altemus et al., 2014).  
Sex differences also exist in behaviour reminiscent of stress-related psychiatric disorders in 
humans (Kokras & Dalla, 2014). However, due to the inherent variability in behavioural testing, 
inconsistencies regarding the direction of sex differences are frequently reported (Kokras & 
Dalla, 2014). Nevertheless, male rodents appear to be more vulnerable to stress-induced 
alterations in behaviour, as anxiety-like behaviour tends to be enhanced by chronic stress to a 
greater extent in males than females (Guo et al., 2004; Bowman et al., 2009). The response to 
severe trauma is also sex-dependent in a rat model of PTSD, where trauma-exposed males 
show a hyporesponsive HPA axis, due to exaggerated negative feedback control mechanisms, 
whereas these findings are not observed in female rats (Pooley et al., 2018).  
Again, sex differences in responses to chronic stress likely depends on the nature of the 
stressor(s), as there appear to be sex-specific differences in the appraisal/perception of how 
stressful a particular experience is. For example, over-crowding has been shown to be more 
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stress-inducing for males, whereas social isolation is more stressful for females (Brown & 
Grunberg, 1995; Palanza, 2001; Ramos-Ortolaza et al., 2017). Thus, resilience and vulnerabilities 
to chronic stress are complex and it is likely that sex-specific vulnerabilities arise from the 
inherently different strategies used to cope with the stressor, rather than an inability to cope 
with the stressor per se (Leuner et al., 2004; Pooley et al., 2018). 
SEX DIFFERENCES IN THE INCIDENCE OF AFFECTIVE DISORDERS IN HUMANS 
Epidemiological studies indicate that men and women display different risk profiles for stress-
related diseases. For instance, women are more prone to developing anxiety, depression, post-
traumatic stress disorder, panic and eating disorders; while men show more antisocial 
behaviour and substance abuse (Altemus et al., 2014; Bangasser & Valentino, 2014). Women 
also report higher incidences of stress, which may be attributed to underlying differences in 
stress responsivity (Wellman et al., 2018). In clinical studies, HPA axis dysregulation is strongly 
implicated in psychiatric disorders. Hyper-secretion of cortisol is linked with mood disorders 
such as major depression or bipolar disorder (Plotsky et al., 1998); whereas hypoactivation of 
the HPA axis is commonly observed in PTSD (Daskalakis et al., 2016). There are also sex 
differences in the interaction between stress-induced cortisol responses and mood disorders, 
where women with depression or anxiety disorders display an overall blunted response to the 
TSST; while in men, an exaggerated response is observed (Zorn et al., 2017). 
Neuroactive steroids and affective disorders 
Deficits in 5α-reduced neuroactive steroids, such as allopregnanolone have been implicated 
to play a role in affective disorders. Depressed patients have lower concentrations of 
allopregnanolone in the plasma and CSF and allopregnanolone levels are negatively correlated 
with depression severity (Romeo et al., 1998; Uzunova et al., 1998; Nappi et al., 2001). In 
support, blocking 5α-reductase with finasteride results in decreased levels of 
allopregnanolone and DHT in the CSF and is associated with the development of anxiety and 
depression symptoms in these men (Melcangi et al., 2013). 
In animal models of postpartum depression, disrupted GABA signalling following dramatic 
changes in the hormonal milieu has been implicated as a causative factor, but neuroactive 
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steroid levels have not been measured (Lonstein et al., 2014). Nonetheless, a recent clinical 
trial has demonstrated therapeutic effects in women with postpartum depression with a 
synthetic allopregnanolone analogue (Kanes et al., 2017), further supporting a role for 
disrupted neuroactive steroid generation and/or action in mood disorders. 
Sex differences in neuroactive steroids in psychiatric disorders  
While the involvement of neurosteroids in rodent models of depression are convincing 
(Maguire, 2019), a role for neuroactive steroids in mediating sex differences in the propensity 
for psychopathology has yet to be investigated. Studies in humans are also lacking. Post-
mortem analysis of brains from male patients with PTSD, indicate lower levels of 
allopregnanolone in the medial prefrontal cortex compared to healthy control males; whereas 
in females increased levels of pregnenolone relative to control females are observed (Cruz et 
al., 2019), which may indicate a deficiency in the conversion of pregnenolone into downstream 
neuroactive metabolites. Consistent with this, another study has demonstrated a decrease in 
the conversion of DHP into allopregnanolone in the plasma of patients with PTSD (Pineles et 
al., 2018), suggesting 3α-HSD dysfunction.  
Taken together the data support a role for both HPA axis dysfunction and deficits in 
neurosteroids in stress-related psychiatric disorders, however far more research is needed to 
establish whether neuroactive steroids, such as allopregnanolone, underlie the distinct sex 
differences in the incidence of stress-related psychiatric disorders between males and females. 
CHANGES IN STEROIDS OVER THE LIFETIME INFLUENCE STRESS RESPONSES AND VICE 
VERSA 
In addition to the robust sex differences in HPA axis activity induced by steroid actions, there 
are dynamic changes in steroid production over the course of the lifetime and as a result 
periods when the ‘set-point’ of the HPA axis is reset and the HPA axis is more or less sensitive 
to stressors (Brunton, 2010; Konkle & McCarthy, 2011; Gupta & Morley, 2014; Green & 
McCormick, 2016; Romeo et al., 2016; Oyola & Handa, 2017). HPA axis activity varies with sex, 
reproductive status, age and disease, with the common link being differences in sex steroid 
levels. Next we will discuss how changes in the steroid milieu and stress exposure during early 
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life, puberty and pregnancy differentially affect HPA axis function and alter the risk for mood 
disorders.  
Sex differences in peripheral and central steroid levels during development 
There are well-established sex differences in the extent to which the brain is exposed to 
testosterone and estradiol during the perinatal period, which contributes to the “organisation” 
of sex differences in the brain. As mentioned above, the male fetal brain is exposed to high 
levels of testosterone from their own testis, which peak in late pregnancy (Ward & Weisz, 1984) 
and surge again shortly after birth (Rhoda et al., 1984). Maternal stress disrupts this 
testosterone surge in male foetuses and is associated with abnormal sexual behaviour in 
adulthood (Ward & Weisz, 1980; Ward & Weisz, 1984). In contrast, testosterone is consistently 
low in the perinatal female rat (Lieberburg et al., 1979). Estradiol and DHT content in the fetal 
brain show a similar pattern in males and females in late pregnancy, with the exception of the 
hypothalamus on embryonic day 21 where estradiol levels are greater in males than females, 
probably as a result of aromatase actions in the brain (Konkle & McCarthy, 2011). Plasma 
estradiol levels are similarly elevated in both male and female rats at birth, before declining 
rapidly, reaching a nadir on PND 4 (Konkle & McCarthy, 2011).  
Allopregnanolone concentrations in the fetal brain are remarkably high in late pregnancy and 
5α-reductase is strongly expressed in the developing rat and sheep brain (Martini et al., 1996; 
Nguyen et al., 2003; Westcott et al., 2008). In the rat, central allopregnanolone concentrations 
in the fetal brain decline before birth, even though central 5α-reductase expression persists, 
probably as a result of declining progesterone (Poletti et al., 1998; Grobin & Morrow, 2001). 
While brain levels of allopregnanolone have not been characterised in the fetus, sex differences 
begin to emerge on PND 25, where concentrations are approximately 2-fold greater in females 
than in males (Grobin & Morrow, 2001).  
The HPA axis in early life 
In rats, CRH and ACTH immunoreactive cells are first identified at around day 16 of gestation 
in the fetal PVN and anterior pituitary, respectively (Schwartzberg & Nakane, 1982; Daikoku et 
al., 1984). ACTH and corticosterone are also detectable in fetal plasma on day 16 of pregnancy 
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(Boudouresque et al., 1988), however hypothalamic control of the fetal HPA axis only develops 
from around day 18 (Eguchi et al., 1973). The fetal HPA axis is capable of responding to 
maternal stress during late gestation (Ohkawa et al., 1991; Williams et al., 1999; Fujioka et al., 
2003), however there appears to be a sex difference with males exhibiting a significant increase 
in ACTH secretion in response to maternal stress from day 18, whereas in females this is not 
observed until day 20 (Ohkawa et al., 1991). Maternal stress-induced increases in 
corticosterone in the fetal circulation are observed earlier, however this is likely of maternal 
origin (Ohkawa et al., 1991). Whereas, given ACTH does not cross the placenta (Dupouy et al., 
1980), the source of ACTH in the fetal circulation is considered to be the fetal pituitary gland.  
In the early postnatal period (from ca. PND 3-14 in rats), the HPA axis is less reactive to stress, 
the so-called ‘stress hyporesponsive period’ (SHRP), which is thought to minimise the risk of 
excessive glucocorticoids disrupting the normal development of glucocorticoid-sensitive brain 
regions (Sapolsky & Meaney, 1986). Hence, in contrast to adults, neonates display a relative 
inability to elicit an ACTH or corticosterone response to certain stressors (Sapolsky & Meaney, 
1986; Levine, 2001). Mother-pup interactions and increased sensitivity to glucocorticoid 
inhibitory feedback, rather than insufficient CRH/AVP production by the mpPVN neurones are 
major contributing factors underlying the SHRP (Walker et al., 1990; Dent et al., 2000). While 
hippocampal GR expression is fairly low at birth, it increases significantly over the first two 
weeks of life, with the highest levels of expression peaking at PND12, which potentiates 
negative feedback inhibition of the HPA axis (Schmidt et al., 2003). It has been suggested that 
increased neurosteroid biosynthesis may contribute to maintain stress hyporesponsiveness 
during infancy as high levels of Akr1c4 expression are detected in the hippocampus on 
postnatal day 7, coinciding with the SHRP in the rat (Mitev et al., 2003), though this remains 
to be thoroughly interrogated. 
Impact of early life stress on HPA axis function 
Stress experienced in early life, either prenatally or in the early postnatal period, is well 
established to have long term ‘programming’ effects on the brain and behaviour (Weinstock, 
2007; Bale et al., 2010; Maccari et al., 2014). The HPA axis is especially vulnerable to the adverse 
effects of chronic stress exposure in early life, with augmented and/or protracted HPA axis 
responses typically observed in rodents exposed to early life stress (Fride et al., 1986; Takahashi 
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& Kalin, 1991; Weinstock et al., 1992; Henry et al., 1994; McCormick et al., 1995; Barbazanges 
et al., 1996; Morley-Fletcher et al., 2003b; Bosch et al., 2007; Mueller & Bale, 2008; Fan et al., 
2009; Brunton & Russell, 2010b). Furthermore, the neonatal SHRP is absent in pups born to 
stressed mothers (Henry et al., 1994) and adult offspring fail to habituate to repeated exposure 
to the same stressor (Fride et al., 1986). Likewise, heightened stress-related behaviours, such 
as anxiety- and depressive-like behaviours and altered stress-coping are frequently reported 
in animals exposed to early life stress (Fride & Weinstock, 1988; Morley-Fletcher et al., 2003a; 
Lee et al., 2007; Mueller & Bale, 2008; Fan et al., 2009; Brunton & Russell, 2010b; Raineki et al., 
2012), with comparable findings in humans (Heim & Nemeroff, 2001; Van den Bergh et al., 
2008; Pawlby et al., 2009).  
Sex differences in early life stress effects 
For both the HPA axis and stress-related behaviours, sex differences are frequently observed 
in the resultant phenotypes induced by early life stress (Weinstock, 2007); for example, males 
often appear more vulnerable to the behavioural effects of prenatal stress than females. 
Exposure of rats to repeated restraint or social stress during the last week of pregnancy both 
result in an anxious phenotype in the adult male, but not in the adult female offspring (Zuena 
et al., 2008; Brunton & Russell, 2010b; Iturra-Mena et al., 2018); with similar sex-specific effects 
on anxiety-like behaviour reported in the male offspring of guinea pigs exposed to chronic 
stress during the second half of pregnancy (Emack et al., 2008). Sex differences in anxiety-like 
behaviour may be a result of the anxiolytic actions of estradiol in females (Walf & Frye, 2007). 
Sex-dependent effects of prenatal stress exposure in early gestation on offspring behaviour 
have also been reported in mice (Mueller & Bale, 2008). Male, but not female prenatally 
stressed offspring show less active stress coping behaviours in the forced swim and tail 
suspension test, and anhedonia in the sucrose preference test; behaviours which are 
considered to be indicative of a depressive-like phenotype (Mueller & Bale, 2008). However, 
these sex differences seem to be dependent on the species, stress paradigm used, the timing 
of the stress exposure and the age of the animals at testing, as some studies report greater 
anxiety- and depressive-like behaviour in the offspring of both sexes (Fride & Weinstock, 1988; 
Butkevich et al., 2019; Verstraeten et al., 2019) or that females are more affected than males 
(Keshet & Weinstock, 1995; Richardson et al., 2006; Sickmann et al., 2015).  
21 
 
Relatively few studies have directly compared the HPA axis response to stress prenatally 
stressed male and female offspring in the same experiment. Under basal conditions, both 
male and female prenatally stressed rats secrete significantly higher levels of corticosterone 
at the end of the light period (Koehl et al., 1999). In terms of HPA axis responses to acute 
stress in prenatally stressed offspring, some studies report responses that are greater in 
amplitude and/or prolonged in both sexes (Smith et al., 2004; Brunton & Russell, 2010b); 
whereas others using different stress paradigms find sex differences where females are more 
severely affected than males (Brunton & Russell, 2010b) or  only females display HPA axis 
hyperactivity (Weinstock et al., 1992; McCormick et al., 1995; Bakker et al., 1998; Richardson 
et al., 2006); again highlighting that effects are dependent on multiple factors. Some of these 
sex differences are likely attributable to sex steroids, as males exposed to neonatal stress by 
maternal deprivation display an anxious phenotype irrespective of their adult gonadal status, 
whereas the anxiogenic effects of early life stress in females only become apparent after 
ovariectomy (Mitev et al., 2003), again supporting an anxiolytic action of estradiol in females 
(Walf & Frye, 2007; Walf et al., 2008). 
In the case of prenatal stress, placental gene expression may also contribute to sex differences 
in adult phenotypes. During pregnancy, placental 11β-hydroxysteroid dehydrogenase 2 (11β-
HSD2) converts maternal glucocorticoids into their inert metabolites to minimise 
transplacental transfer of glucocorticoids and protect the fetus from glucocorticoid over-
exposure (Benediktsson et al., 1997). However, there are sex differences in the effect of 
maternal stress on the activity of this enzyme. For example, in mice, stress exposure in mid-
gestation increases placental 11β-HSD2 (Hsd11b2) gene expression in both sexes (though the 
increase is delayed in females), but increased 11β-HSD2 activity is only observed in males; 
which leads to increased glucocorticoid exposure in the female foetuses (Wieczorek et al., 
2019). We have also recently found similar sex-specific effects on Hsd11b2 gene expression in 
rats exposed to social stress in late pregnancy (Sze, Fernandes & Brunton, unpublished 
observations). Given exposure to excessive levels of glucocorticoids during pregnancy has 
adverse effects on the developing fetal brain and results in HPA axis dysfunction (Welberg et 
al., 2000; Welberg et al., 2001; Banjanin et al., 2004; Dunn et al., 2010), sex-specific differences 
in placental 11β-HSD2 expression and the resultant differences in fetal glucocorticoid 
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exposure, may contribute to sex differences in adult behaviours and HPA axis responsivity 
following prenatal stress.   
Furthermore, stress in early pregnancy in mice results is a sex-specific effect on the expression 
of genes that support the fetal transport of critical growth factors and nutrients, such as 
peroxisome proliferator-activated receptor-α (PPARα) and insulin-like growth factor binding 
protein-1 (IGFBP-1). While prenatal stress increases PPARα (Ppara) and IGFBP-1 (Igfbp1) gene 
expression in male placentas, the opposite effect is observed in female placentas (Mueller & 
Bale, 2008). Given PPARα directly increases the expression of Igfbp1 (Degenhardt et al., 2006) 
and increases in placental IGFBP-1 result in a decrease in available growth factors (as IGFBP-1 
blocks insulin-like growth factors binding to the insulin receptor), differential responses of this 
gene to stress may contribute to sex differences in fetal programming.  
Mechanisms involved in early life programming 
A plethora of studies have sought to understand the central mechanisms underpinning early 
life programming of the stress system and behaviour. Evidence for increased excitatory drive 
to the CRH neurones in the PVN, impaired glucocorticoid negative feedback control, altered 
glutamatergic signalling in the prefrontal cortex, amygdala and hippocampus and altered 
signalling via central CRH receptors have been reported and reviewed elsewhere (Henry et al., 
1994; Mueller & Bale, 2008; Zuena et al., 2008; Fan et al., 2009; Brunton & Russell, 2010b; 
Brunton et al., 2011; Laloux et al., 2012; Marrocco et al., 2012; Gunn et al., 2013; Maccari et al., 
2014; Marrocco et al., 2014; Buonaguro et al., 2019). Here, we focus on a potential role for 
altered neurosteroidogenesis in mediating some of the impacts of early life stress and the 
underlying sex differences.   
Early life stress and neurosteroidogenesis 
Maternal exposure to prolonged stress or high levels of exogenous glucocorticoids during 
pregnancy appears to reduce the neurosteroidogenic capacity of the fetal brain in rodents, 
much like chronic stress in adulthood does (discussed above). In rats, maternal stress in late 
pregnancy reduces 5α-reductase activity in the brain of male foetuses (females were not 
studied)(Ordyan & Pivina, 2005) and reduces circulating allopregnanolone levels in the dams; 
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which predicts lower allopregnanolone generation in both the male and female offspring’s 
brain in later life (Paris & Frye, 2011b). In guinea pigs, treatment with the synthetic 
glucocorticoid, betamethasone in late pregnancy, leads to reduced gene expression for 5α-
reductase type 2 (Srd5a2) in the brain of male, but not female foetuses (McKendry et al., 2010); 
whereas 5α-reductase type 1 (Srd5a1) mRNA expression in the brain is increased by 
betamethasone treatment in female foetuses, but not in males (McKendry et al., 2010). Preterm 
birth (which leads to a premature decline in allopregnanolone levels and increased 
glucocorticoid secretion in the neonate) also leads to a reduction in the expression of key 
GABAA receptor subunits that normally increase neurosteroid sensitivity in both the male and 
female neonates (Shaw et al., 2015; Hirst et al., 2016). 
Reduced 5α-reductase activity in the fetal brain following maternal stress seems to persist into 
later life, as both the male and female juvenile offspring of rats exposed to chronic stress 
during pregnancy show reduced conversion of progesterone into its 5α-reduced metabolite, 
DHP in the medial prefrontal cortex (Paris & Frye, 2011b; Paris & Frye, 2011a); whereas in the 
diencephalon, DHP is increased in prenatally stressed females, but decreased in prenatally 
stressed males (Paris & Frye, 2011a). In adulthood, the male offspring (again females were not 
studied) of rat dams exposed to repeated stress in late gestation, have lower hippocampal 
levels of the 5α-reduced metabolites of testosterone, DHT and 3α-diol and this is associated 
with greater corticosterone responses to stress and heightened anxiety behaviour (Walf & 
Frye, 2012). Moreover, we have shown sex-dependent effects of maternal social stress in late 
gestation on 5α-reductase gene expression in the hypothalamus and medulla of the adult 
offspring: expression in the NTS is reduced in both male and female prenatally stressed rats, 
whereas in the PVN, Srd5a1 expression is reduced only in the male offspring (Brunton et al., 
2015). The mechanism underlying the sex-dependent effects of prenatal stress on central 5α-
reductase expression, activity, and consequently neurosteroid production is not clear, though 
differences in circulating testosterone may contribute (Torres & Ortega, 2006; Purves-Tyson et 
al., 2012; Sanchez et al., 2012). Indeed, 5α-reductase activity in the liver is programmed during 
the first week of life by testicular androgens, hence testectomy stimulates, while testosterone 
administration inhibits hepatic 5α-reductase activity (Gustafsson & Stenberg, 1974). 
Consistent with this theory, prenatally stressed male rats with increased plasma testosterone 
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concentrations (Brunton et al., 2015) also exhibit lower hepatic 5α-reductase gene expression 
(Brunton et al., 2013). 
Stress exposure in early postnatal life has similar effects to prenatal stress on 5α-reductase 
activity, however only a few studies have investigated whether reduced 5α-reductase leads to 
reduced neuroactive steroid concentrations in the brain of animals stressed in early life. Male 
juveniles exposed to chronic psychosocial stress from weaning, exhibit significantly lower 
protein expression of both 5α-reductase isoforms in the medial prefrontal cortex and nucleus 
accumbens, concomitant with reduced allopregnanolone and THDOC content in the frontal 
cortex (Bortolato et al., 2011); and reduced DHP synthesis is observed in the brains of male 
and female neonates exposed to stress via daily separation from the dam and littermates 
during the first 9 days of life (Kehoe et al., 2000). Moreover, social isolation in juvenile male 
rats at weaning results in markedly reduced levels of allopregnanolone and THDOC in the 
blood and brain and reduced central GABAA receptor function, which is associated with 
increased anxiety-like behaviour, increased sensitivity of the pituitary corticotrophs to CRH and 
impaired negative feedback control of the HPA axis (Serra et al., 2000; Serra et al., 2005). 
Similar findings have been reported for central allopregnanolone and THDOC levels in female 
rats reared in isolation from weaning, which are also more anxious compared with socially-
reared rats (Pisu et al., 2013). More recently, the same group have made direct comparisons 
between male and female rats reared in social isolation in early life and demonstrated that the 
chronic stress associated with social isolation at weaning, reduces basal levels of circulating 
and central allopregnanolone to a similar extent in both sexes (Pisu et al., 2016). Glucocorticoid 
feedback inhibition of the HPA axis is also impaired in both sexes, and males and females 
display markedly greater corticosterone responses to acute stress compared with group-
housed animals. However this effect is more pronounced in male rats than in 
females subjected to social isolation; and only socially isolated males display depressive-like 
behaviour (Pisu et al., 2016). 
Stress in early life also disrupts neuroactive steroid action in the brain. In mice, early life stress 
induced by fragmented maternal care results in increased excitatory afferent drive to the 
parvocellular CRH neurones in the PVN and up-regulated Crh gene expression (Gunn et al., 
2013). Intriguingly, while allopregnanolone is effective in suppressing the neuronal firing rate 
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of PVN CRH neurones in control mice, this action is compromised by prior early life stress 
exposure (Gunn et al., 2013). This insensitivity to allopregnanolone evidently results from 
increased glutamatergic drive to the CRH neurones, rather than disrupted GABAergic 
signalling (Gunn et al., 2013), however it is not known whether any sex differences exist in the 
degree of allopregnanolone insensitivity.  
A role for neuroactive steroids in counteracting early life stress effects 
Given the findings that early life stress disrupts neurosteroidogenesis, in particular 5α-reduced 
steroid production, it has been hypothesised that this may underlie some of the adverse effects 
of early life stress; such as HPA axis dysregulation and increased anxiety-like behaviour. 
Therefore studies have investigated whether neuroactive steroid treatment can prevent or 
reverse the programming effects of perinatal stress exposure. Administration of 
allopregnanolone to pregnant rats in conjunction with stress exposure, prevents the increase 
in anxiety-behaviour typically induced by prenatal stress in the neonatal and adult offspring 
(Zimmerberg & Blaskey, 1998) and reduces ultrasonic vocalizations in rat pups induced by 
maternal separation (Zimmerberg et al., 1994; Vivian et al., 1997). Similarly, THDOC 
administered during extended periods of maternal deprivation in the early postnatal period, is 
effective in preventing the neuroendocrine and behavioural consequences of neonatal stress, 
including exaggerated HPA axis responses to stress, impaired glucocorticoid feedback control 
of the HPA axis and increased anxiety behaviour in males (females were not studied) (Patchev 
et al., 1997); while similar treatment with allopregnanolone counteracts these adverse effects 
in both sexes (Mitev et al., 2003). 
In adulthood, short-term allopregnanolone administration is effective in attenuating the 
hyperactive HPA axis responses usually observed in prenatally stressed females, but not in 
their male littermates (Brunton et al., 2015). However, treatment with the testosterone 
metabolite, 3β-diol, does normalise enhanced HPA axis responses to stress in the adult 
prenatally stressed male offspring (Brunton et al., 2015).  Furthermore, up-regulating Srd5a1 
and Akr1c4 gene expression in the brainstem using adenoviral vectors also prevents 
hyperactive HPA axis responses to acute stress in prenatally stressed rats (Brunton et al., 2015), 
presumably by enhancing local neurosteroid synthesis, though this remains to be tested. 
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Taken together these data indicate that neuroactive steroids, especially those that act as 
GABAA receptor agonists, may protect the developing brain from the adverse effects of 
perinatal stress or reverse the neuroendocrine effects when administered in later life. The 
mechanisms involved are not clear, but GABAA receptors are likely targets for 
allopregnanolone and THDOC actions, given their affinity for these receptors and their potent 
stress-suppressing and anxiolytic actions through potentiating GABA signalling (Patchev et al., 
1994; Patchev et al., 1996). Indeed, there is evidence that the suppressive effect of 
allopregnanolone on ultrasonic vocalisations induced by maternal separation is mediated by 
GABAA receptors (Vivian et al., 1997). In contrast, 3β-diol modulates HPA axis responses and 
anxiety-like behaviour through actions on estrogen receptor-β in the PVN (Lund et al., 2006; 
Weiser et al., 2009); though it has yet to be established if this is how it exerts its effects in 
prenatally stressed rats (Brunton et al., 2015).  
Sex differences in the sensitivity of central GABAA receptors to neurosteroids have been 
reported, with females exhibiting greater sensitivity to the anti-seizure and neuroprotective 
effects of allopregnanolone (Kelley et al., 2011; Reddy et al., 2019). Whether this is also the 
case for GABAA-mediated actions on HPA axis activity is not known, but warrants investigation.  
Sex-specific effects of paternal stress on the offspring 
In recent years, some researchers have begun to investigate the impact of chronic paternal 
stress around the time of conception on offspring HPA axis function. The limited evidence 
indicates paternal stress also results in dysregulated HPA axis responses to stress in the 
offspring, though the direction of the change seems dependent on the stress paradigm used. 
One study in mice reported, increased basal plasma concentrations of corticosterone in the 
male, but not female offspring (Dietz et al., 2011); whereas another reported elevated baseline 
corticosterone levels in the offspring of both sexes, concomitant with reduced hippocampal 
GR expression (Niknazar et al., 2017). In both studies, the male and female offspring of stressed 
fathers exhibited heightened anxiety-like behaviours (Dietz et al., 2011; Niknazar et al., 2017). 
In contrast to the effect of maternal stress, the offspring of stressed fathers appear to display 
attenuated HPA axis responses to acute stress exposure in later life (Rodgers et al., 2013; 
Rodgers et al., 2015), which may result from epigenetic reprogramming of the sperm (Rodgers 
et al., 2015). However to date, and to the best of our knowledge, no studies have investigated 
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a role for altered neurosteroidogenesis in mediating the impact or the downstream 
consequences of paternal stress on the offspring. 
Sex differences in HPA axis function at puberty 
Puberty is accompanied by dynamic changes in circulating adrenal and gonadal steroids in 
males and females, which contribute to the organisation and maturation of the HPA axis (Viau 
et al., 2005). Basal concentrations of circulating testosterone are significantly greater in post-
pubertal males compared with pre-pubertal males, while in females, plasma estradiol, 
progesterone and corticosterone levels are all significantly greater after puberty (Viau et al., 
2005). It is unsurprising therefore, that these changes in sex and adrenal steroids at puberty 
are associated with altered HPA axis responsivity. For example, compared with post-pubertal 
males, pre-pubertal males display greater ACTH and corticosterone responses to acute stress 
(Vazquez & Akil, 1993) and stress-induced Fos induction and Avp gene transcription in the 
mpPVN is significantly lower after puberty (Viau et al., 2005). This shift in HPA responsiveness 
in males at puberty corresponds with increased plasma testosterone levels (Romeo et al., 
2004), which inhibits HPA axis function (Viau et al., 2003; Lund et al., 2004). In contrast, stress-
induced increases in ACTH and corticosterone secretion are greater in post-pubertal in females 
than in pre-pubertal females, despite similar levels of stress-induced Fos and Avp gene 
transcription in the mpPVN (Viau et al., 2005), further supporting the idea that there are distinct 
sex differences in the regulation of the HPA axis at puberty.   
Heightened stress reactivity around puberty may put adolescents at higher risk for 
psychopathology, and explain the increasing incidences of psychiatric disorders that arise 
during adolescence (Gunnar & Quevedo, 2007; Paus et al., 2008). Indeed, sex differences in the 
risk for mood disorders rise sharply after puberty. For example, after puberty, incidences of 
major depression are two times higher in females compared to males and remain so until after 
menopause (Altemus et al., 2014). The onset of puberty is also associated with increases in 
anxiety disorders, which are twice as likely to occur in girls as in boys (Hayward & Sanborn, 
2002). In female mice, hippocampal allopregnanolone concentrations decline by around 50% 
at the onset of puberty (Shen et al., 2007). However in contrast to its robust anxiolytic action 
in adults, allopregnanolone paradoxically increases anxiety-like behaviour in pubertal female 
mice (Shen et al., 2007), which may be a result of allopregnanolone withdrawal as similar 
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findings are observed in a rodent model of premenstrual dysphoric disorder, where increases 
in allopregnanolone levels also exert anxiogenic effects (Smith et al., 2006).  
Pregnancy 
Steroid milieu of pregnancy 
One period during a female’s life when steroid production is dramatically altered is during 
pregnancy. Circulating levels of the female sex steroids, estradiol and progesterone are 
considerably increased in pregnancy (Fig. 5) (Brunton & Russell, 2010a; Brunton et al., 2014) 
providing a unique model in which to study the impact of these steroids (and their metabolites) 
on HPA axis function.  
In the periphery, estradiol and progesterone act on the uterus to ensure optimal conditions 
for maintenance of pregnancy. In the rat, progesterone secretion by the corpus luteum steadily 
increases, peaking around day 15 and remaining elevated until ca. 2 days before term when 
there is a sharp decline in circulating progesterone concentrations (Fig. 5) (Brunton & Russell, 
2010a). Estradiol secretion increases on day 4 of pregnancy, which coincides with implantation, 
then declines and fluctuates at intermediate levels until increasing towards the end of 
pregnancy, reaching a maximum on day 21 of gestation (Fig. 5) (Shaikh, 1971; Brunton & 
Russell, 2010a). In addition, to actions on the uterus to sustain the pregnancy, estradiol and 
progesterone also act in the brain, for example in the mPOA, to prime the neural circuitry 
necessary for the expression of appropriate maternal care after parturition (Bridges, 1984; 
Numan, 2007). 
Concomitant with increased concentrations of progesterone in the brain and circulation in late 
pregnancy, is an increase in central and peripheral levels of its 5α-reduced metabolite, 
allopregnanolone (Concas et al., 1998). However, unlike progesterone, allopregnanolone in the 
cerebral cortex does not reach maximal levels until later in pregnancy, at around day 19 (Fig. 
5) (Concas et al., 1998). Similarly, concentrations of another neuroactive steroid metabolite, 
THDOC is also markedly increased in the blood and brain in late pregnancy (Fig. 5) (Concas et 
al., 1998). Consistent with these findings, gene expression and activity of the enzyme, 5α-
reductase is increased in the hypothalamus and medulla in late pregnancy (Brunton et al., 
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2009), as are concentrations of the steroid precursor, pregnenolone (Concas et al., 1998), 
suggesting local neuroactive steroid generation may play an important role in pregnancy. The 
mechanism through which central 5α-reductase and 3α-HSD expression are regulated in 
pregnancy are not clear. The available evidence does not support a role for either estradiol or 
progesterone in regulating Srd5a gene expression in the brain, however increased levels of 
prolactin in pregnancy may play a role (Sanchez et al., 2008b). On the other hand, estradiol 
does appear to regulate Akr1c4 expression in the brain (Bertics et al., 1987; Mitev et al., 2003). 
The maternal HPA axis in pregnancy 
In early pregnancy in the rat, ACTH and corticosterone secretion at the circadian nadir are 
similar to those observed in non-pregnant rats. However, there is a marked change in the 
circadian rhythm of ACTH and corticosterone secretion in pregnancy. By day 2 of pregnancy 
the diurnal peak in ACTH secretion is suppressed by around one third of pre-pregnancy levels 
and remains so for the remainder of gestation. Peak corticosterone secretion is also similarly 
reduced by day 2 of pregnancy, however after day 10 both trough and peak corticosterone 
concentrations progressively increase, reaching a maximum on day 22. It is likely that increased 
corticosterone secretion, in the absence of an increase in ACTH secretion is the result of the 
adrenal gland becoming more sensitive to ACTH as a result of estradiol actions (Viau & 
Meaney, 1991). Similar observations have been made in pregnant women where cortisol levels 
are lower in early pregnancy before increasing in late pregnancy and it is thought that reduced 
glucocorticoid levels in early pregnancy may facilitate implantation (Allolio et al., 1990; 
Nepomnaschy et al., 2015). 
In the first half of pregnancy, HPA axis responses to acute physical or psychological stressors 
are similar to those of non-pregnant females, however in late pregnancy the HPA axis becomes 
hyporesponsive to acute stress exposure (for review see (Brunton et al., 2008)). This is indicated 
by reduced or even a complete absence of an ACTH and/or corticosterone secretory response 
to an array of both physical, and psychological stressors, as well as for stressors containing 
both psychological and physical elements (da Costa et al., 1996; Douglas et al., 1998; Neumann 
et al., 1998; Brunton & Russell, 2003; Brunton et al., 2005; Brunton et al., 2006; Brunton & 
Russell, 2008a; Windle et al., 2010). This has been demonstrated most extensively in the rat, 
but suppressed HPA axis responses to acute stress are also reported in late pregnant mice 
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(Douglas et al., 2003) and women (Schulte et al., 1990; Hartikainen-Sorri et al., 1991; Kammerer 
et al., 2002). Reduced HPA axis activity in late pregnancy is a result of adaptations in the 
anterior pituitary (Neumann et al., 1998), reduced excitatory drive from limbic brain regions 
and the brainstem to the parvocellular CRH and AVP neurones in the PVN (da Costa et al., 
1996; Brunton et al., 2005; Douglas et al., 2005), reduced secretion of ACTH secretagogues by 
the PVN neurones (Ma et al., 2005) and slow glucocorticoid negative mechanisms mediated 
by the hippocampus (Johnstone et al., 2000).  
Steroids and suppressed HPA axis responses in pregnancy 
Despite increasing concentrations of female sex steroids coinciding with the manifestation of 
HPA axis hyporesponsiveness in pregnancy (Fig. 5), increased levels of estradiol and 
progesterone evidently do not play a role in the initiation or maintenance of suppressed HPA 
axis responses. Administration of estradiol or progesterone alone or in combination to mimic 
the steroid milieu of pregnancy in virgin rats is not sufficient to simulate the HPA axis 
hyporesponsiveness seen in late pregnancy (Douglas et al., 2000; Brunton et al., 2009).  
In late pregnancy, it is in fact increased levels of allopregnanolone that act to restrain the HPA 
axis from responding to stress. Hence inhibiting allopregnanolone synthesis in late pregnant 
rats with the 5α-reductase inhibitor, finasteride, reinstates HPA axis responses to stress in late 
pregnancy (Brunton et al., 2009). This treatment would also be expected to block THDOC 
production, however consistent with a role for allopregnanolone as the critical factor is the 
finding that allopregnanolone is able to supress HPA axis responses to stress in non-pregnant 
females (Brunton et al., 2009). However the allopregnanolone precursors, progesterone and 
DHP are both ineffective in attenuating stress-induced ACTH secretion (Brunton et al., 2009), 
highlighting the importance of central neurosteroidogenic enzymes in suppressed HPA axis 
responses to stress in pregnancy. 
Allopregnanolone exerts its inhibitory effects on HPA axis stress responses by induction of a 
central endogenous opioid mechanism. In late pregnancy, endogenous opioids inhibit HPA 
axis responses to stress (Douglas et al., 1998; Brunton et al., 2005), evidently through actions 
in the PVN (Brunton et al., 2005). The origin of these endogenous opioids is thought to be NTS 
neurones that project to the PVN. Indeed, gene expression for the opioid precursor, 
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proenkephalin-A (Penk) and the mu-opioid receptor (Oprm1) is significantly increased in 
brainstem NTS neurones in late pregnancy (Brunton et al., 2005). Importantly, up-regulation 
of Penk is prevented in pregnant animals if allopregnanolone synthesis is blocked with 
finasteride, and this same treatment also restores stress-induced ACTH secretion in late 
pregnancy (Brunton et al., 2009). Moreover, allopregnanolone administration to non-pregnant 
female rats induces a similar increase in opioid gene expression in the NTS and induces 
inhibitory opioid tone over the HPA axis, leading to attenuated HPA axis responses to stress 
(Brunton et al., 2009). The mechanism by which allopregnanolone up-regulates endogenous 
opioid expression has yet to be elucidated, but it may involve an interaction with GABAA 
receptors as previously demonstrated for transcriptional regulation of CRH and AVP in the 
PVN  (Bali & Kovacs, 2003).  
Suppressed HPA axis responses to stress in pregnancy are anticipated to provide a protective 
mechanism to minimise fetal exposure to excessive levels of maternal glucocorticoids and 
thereby reduce the risk of adverse fetal programming, but also to support metabolic 
adaptations in pregnancy (Herrera, 2000). Nonetheless, it clear that this protective mechanism 
can be breached as exposure to chronic or repeated stress during pregnancy leads to adverse 
outcomes in the offspring, as described above. Few studies have focussed on maternal HPA 
axis responses to chronic stress in pregnancy. However, in rats, chronic social stress elicits a 
significant corticosterone response in both early and late pregnancy (Stefanski et al., 2005; 
Brunton & Russell, 2010b) and chronic stress induces a significant increase in ACTH and 
corticosterone secretion in late pregnant rats (Takahashi et al., 1998; Maghsoudi et al., 2014). 
Chronic social stress in male rodents has been shown to reduce Srd5a1 expression, 5α-
reductase activity and allopregnanolone levels in the brain and it is thought that this leads to 
HPA axis hyperactivity (Serra et al., 2000; Dong et al., 2001; Matsumoto et al., 2005; Agis-Balboa 
et al., 2007; Evans et al., 2012). It is not clear whether chronic social stress has a similar effect 
in late pregnancy, however if this were the case, it may explain why HPA axis responses to 
chronic stress are not effectively dampened in pregnancy and this may contribute to the 
programmed phenotypes observed in the offspring. 
Pregnancy represents a period in the female’s life when there is an increased allostatic load 
and changes in HPA axis responsiveness are not without cost. The sudden withdrawal of the 
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pregnancy hormones around birth may predispose the mother to postpartum depression 
(Brunton & Russell, 2008b). Women who have experienced postpartum depression show 
greater sensitivity to experimental estrogen and progesterone withdrawal (Bloch et al., 2000) 
and the withdrawal of estradiol and progesterone induces depression-like behaviour in rat 
models of postpartum depression (Galea et al., 2001; Stoffel & Craft, 2004). These data suggest 
that a loss of neurosteroid action in the brain may contribute to the manifestation of 
postpartum depression in vulnerable women. Indeed, as mentioned above, recent clinical trials 
have demonstrated that an allopregnanolone analogue (brexanolone) with positive allosteric 
actions at GABAA receptors is effective in the treatment of postpartum depression (Kanes et 
al., 2017; Meltzer-Brody et al., 2018). It is not known whether such treatments are also effective 
in treating other types of psychiatric disorders, such as major depressive disorder in men or 
non-pregnant women, however phase 2 clinical trials are currently underway (Hoffman et al., 
2019). 
CONCLUDING REMARKS 
Sex differences in HPA axis responsivity are well established, with females generally displaying 
greater reactivity than males. Differences in gonadal sex steroids and their neuroactive 
metabolites are largely responsible for sex differences in HPA axis responses to acute stress. 
This is further supported by the finding that changes in gonadal/neuroactive steroids that 
occur naturally at different times of life e.g. in the perinatal period, at puberty and during 
pregnancy, are reflected by concordant changes in the responsivity of the HPA axis.  
Chronic stress or stress experienced during critical periods in development, such as the 
perinatal period, can lead to deficits in neuroactive steroid production and HPA axis 
dysfunction. HPA axis dysregulation is a common feature of stress-related psychiatric disorders 
and reduced levels of neuroactive steroids are implicated in altered emotionality in animal 
models and affective disorders in humans. A causative link between these two factors has yet 
to be fully established, however the findings from rodent early life stress models where 
neuroactive steroids can prevent or reverse dysregulated HPA axis function and normalise 
anxious behaviours, suggest that disruptions in neurosteroidogenesis underpin HPA axis 
dysregulation, rather than the opposite scenario. 
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Women are far more likely to be affected by mood disorders, however the evidence described 
in this review only indirectly supports a potential role for neuroactive steroids in the sex bias 
in stress-related psychopathologies. Progress in this area has been hampered by the apparent 
reluctance of many researchers to study females and the paucity of direct comparative studies 
between males and females. This is problematic as findings based on only one sex may lead 
to inaccurate conclusions and limit the effectiveness of any therapeutic interventions in the 
sex that is neglected (typically females). For example, given the marked sex differences in 
steroid production and hence stress axis regulation, therapeutics targeting steroid signalling 
pathways to treat stress-related psychiatric disorders may differ in efficacy between males and 
females. With this in mind there is an obvious need for future research to take into account 
both sexes, only then may we fully understand the factors that are crucial in accounting for sex 
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3α-HSD, 3α-hydroxysteroid dehydrogenase 
3β-diol, 3β-androstanediol 
3β-HSD, 3β-hydroxysteroid dehydrogenase 
11β-HSD2, 11β-hydroxysteroid dehydrogenase 2 
ACTH, adrenocorticotropic hormone 
AR, androgen receptor 
AVP, arginine vasopressin 
BNST, bed nucleus of the stria terminalis 
CBG, corticosteroid-binding globulin 
CRH, corticotropin-releasing hormone 





ER, estrogen receptor 
GABA, γ-aminobutyric acid 
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GR, glucocorticoid receptor 
HPA, hypothalamo-pituitary-adrenal 
IGFBP-1, insulin-like growth factor binding protein-1 
mPOA, medial preoptic area 
mpPVN, medial parvocellular paraventricular nucleus 
MR, mineralocorticoid receptor 
NTS, nucleus of the solitary tract 
p450scc, p450 side-chain cleavage enzyme 
PPARα, peroxisome proliferator-activated receptor-α 
PND, post-natal day 
PR, progesterone receptor 
PTSD, post-traumatic stress disorder 
PVN, paraventricular nucleus 
SHRP, stress hyporesponsive period’ 
StAR, steroidogenic acute regulatory protein 
THDOC, tetrahydrodeoxycorticosterone 
TSST, Trier Social Stress Test 
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Figure 1: Sex differences in HPA axis responses to acute stress 
Summary of the key factors underpinning greater activation of the HPA axis in female rodents 
(♀) than in males (♂) following acute stress. Abbreviations: ACTH, adrenocorticotropic 
hormone; AVP, arginine vasopressin; CORT, corticosterone; CRH, corticotropin-releasing 
hormone; GR, glucocorticoid receptor; mpPVN, medial parvocellular paraventricular nucleus; 
MR, mineralocorticoid receptor; + stimulatory action; -, inhibitory action.  
Figure 2: The organisational-activational hypothesis of steroid action 
The organisational-activational theory explains the role steroids play in determining sex 
differences in physiological stress responses. The organisational effects of steroids are exerted 
during critical periods of development such as during the fetal/postnatal testosterone surge 
or during puberty, where they act as morphogens to organise the neural circuitry. During 
adulthood, steroids act as allostatic mediators of stress, modulating gene expression or 
neuronal signalling, and augmenting or compensating for differences in neural circuitries that 
were determined earlier by the organisational effects of steroids. Sex differences in stress 
responses in adulthood are thus a result of an amalgation of the effects of steroids both in 
early life (“organisational” effects) and during adulthood (“activational” effects).  
Figure 3: Biosynthetic pathways involved in steroidogenesis  
Cholesterol enters the mitochondria (facilitated by the steroidogenic acute regulatory protein; 
StAR) and is cleaved by the p450 side-chain cleavage enzyme (p450scc) into pregnenolone. 
Pregnenolone can be converted to progesterone by 3β-hydroxysteroid hydrogenase (3β-
HSD), which can subsequently be converted to deoxycorticosterone (DOC), then 
corticosterone. Corticosterone can be converted to the mineralocorticoid aldosterone by 
aldosterone synthase. Progesterone and DOC can also undergo two sequential A-ring 
reduction steps to form the 5α,3α-reduced steroids, allopregnanolone and 
tetrahydrodeoxycorticosterone (THDOC), respectively. These reduction steps are catalysed by 
the enzymes 5α-reductase and 3α-hydroxysteroid dehydrogenase (3α-HSD), respectively. 
Reactions catalysed by 3α-HSD are reversible, hence allopregnanolone and THDOC can be 
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oxidised to DHP and DHDOC, respectively. Pregnenolone and progesterone can be converted 
to androgens by a two-step pathway, catalysed by the 17-hydroxylase and 17,20-lyase 
activities of a single enzyme, cytochrome P450c17. Testosterone can similarly be reduced to 
form dihydrotestosterone (DHT), and subsequently 3α-androstanediol (3α-diol) and 3β-
androstanediol (3β-diol). Lastly, testosterone can also be converted to 17β-estradiol via the 
actions of aromatase (Cyp19a1). Chemical modifications such as sulfation may also change the 
properties and functions of steroids such as dehydroepiandrosterone (DHEA) and 
pregnenolone. Chemical structures of cholesterol, pregnenolone, progesterone, 5α-DHP and 
allopregnanolone are given as examples of the conversion by steroidogenic enzymes, where 
stereochemistry is an important aspect of each reaction. 
Figure 4: Genomic and non-genomic action of steroids  
Non-genomic actions of steroids in the brain are mediated through membrane-bound (m) 
steroid receptors or neurotransmitter receptors such as NMDA or GABAA receptors, resulting 
in rapid cellular changes involving the activation of intracellular signalling pathways (in the 
case of membrane-bound steroid receptors) or the changes in the membrane potential (in the 
case of neurotransmitter receptors). For genomic actions, steroids exert their effects via 
classical steroid receptor actions, where upon ligand binding, chaperone proteins dissociate, 
allowing two steroid-receptor complexes to dimerise. Dimerised receptors then enter the 
nucleus and bind to steroid responsive elements on genes to alter gene transcription and 
subsequently protein expression. Examples of steroid ligands that may bind to each receptor 
are listed below the receptors. Notably, steroids such as THDOC and allopregnanolone are 
allosteric modulators, therefore bind to a site away from the site of neurotransmitter binding. 
Abbreviations: 3β-diol, 3β-androstanediol; ALLO, Allopregnanolone; AR, androgen receptor; 
CORT, cortisol (in humans) or corticosterone (in rats and mice); DHEA, 
dehydroepiandrosterone; DHP, dihydroprogesterone; DHT, dihydrotestosterone; E2, estradiol; 
ER, estrogen receptor; GR, glucocorticoid receptor; (m), membrane bound; MR, 
mineralocorticoid receptor; PR, progesterone receptor; PregS, pregnenolone sulfate; Prog, 




Figure 5: Steroid hormone profiles in the plasma and brain during pregnancy in the rat 
a) Circulating concentrations of allopregnanolone, estradiol, progesterone and 
tetrahydrodeoxycorticosterone (THDOC); and b) concentrations of allopregnanolone, 
progesterone and THDOC in the cerebral cortex of pregnant rats. In each case hormone 
concentrations are expressed as a percentage of the maximum levels found in pregnancy. Data 
are derived from previously published studies (Concas et al., 1998; Mann & Bridges, 2001). N.b. 
Estradiol concentrations in the brain across pregnancy are not available, possibly due to poor 
detection limits of the available assays (Toran-Allerand et al., 2005; Meffre et al., 2007).   
 
